Prevalence and Risk Factors for New-Onset Hypertension in Labor

Abstract

Objective Little is known about prevalence, risk factors, rate of treatment, or adverse outcomes associated with intrapartum hypertension. Thus, our objective was to describe these findings.

Study Design This was a retrospective study of laboring term gestations with no history of hypertensive disorders. Intrapartum blood pressures were reviewed, and women were subdivided based on blood pressures: normal (<140 mm Hg systolic and <90 mm Hg diastolic), mild hypertension (140–159 or 90–109), and severe hypertension (≥ 160 or ≥ 110). Groups were compared using chi-square test and analysis of variance.

Results A total of 724 women were studied during 4 months: 248 (34%) had mild and 69 (10%) had severe hypertension. Severe hypertensives were more likely to be nulliparous, obese, or have received an epidural or oxytocin. There were no cases of eclampsia, stroke, or pulmonary edema in severe hypertensives (95% confidence interval, 0–5). Despite severely elevated pressures, only 4/69 (6%) patients received intravenous antihypertensive therapy, and 3 (4%) required medications at discharge.

Conclusion One in 3 women exhibits mild hypertension and 1 in 10 develop severe hypertension in labor. Only 6% of patients received treatment for severe blood pressures. This study highlights lack of treatment of hypertension in labor and further investigation into causes and outcomes of intrapartum elevations of blood pressures.

Keywords

hypertension - labor - nulliparity - obesity

Note

This study was presented as a poster at the Society of Maternal-Fetal Medicine, January 23–27, 2017, Las Vegas, NV.

• References

• 1 Hirshberg A, Srinivas SK. Epidemiology of maternal morbidity and mortality. Semin Perinatol 2017; 41 (06) 332-337
• 2 Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013
• 3 Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol 2012; 206 (06) 470-475
• 4 Ohno Y, Terauchi M, Tamakoshi K, Shiozaki A, Saito S. The risk factors for labor onset hypertension. Hypertens Res 2016; 39 (04) 260-265
• 5 Cohen J, Vaiman D, Sibai BM, Haddad B. Blood pressure changes during the first stage of labor and for the prediction of early postpartum preeclampsia: a prospective study. Eur J Obstet Gynecol Reprod Biol 2015; 184: 103-107
• 6 Ankumah NE, Blackwell SC, Alrais MA. , et al. Liberal versus indicated maternal oxygen supplementation in labor: a before-and-after trial. Am J Perinatol 2018; 35 (11) 1057-1064
• 7 Committee on Obstetric Practice. Committee opinion no. 692: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2017; 129 (04) e90-e95
• 8 Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365 (9461): 785-799
• 9 Pickering TG. Effects of stress and behavioral interventions in hypertension. Pain and blood pressure. J Clin Hypertens (Greenwich) 2003; 5 (05) 359-361
• 10 Porth CJ, Bamrah VS, Tristani FE, Smith JJ. The Valsalva maneuver: mechanisms and clinical implications. Heart Lung 1984; 13 (05) 507-518
• 11 Ducros L, Bonnin P, Cholley BP. , et al. Increasing maternal blood pressure with ephedrine increases uterine artery blood flow velocity during uterine contraction. Anesthesiology 2002; 96 (03) 612-616
• 12 Davies GA, Tessier JL, Woodman MC, Lipson A, Hahn PM. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial. Obstet Gynecol 2005; 105 (02) 294-299
• 13 Lappen JR, Myers SA, Bolen N, Mercer BM, Chien EKS. Maternal pulse pressure and the risk of postepidural complications: a randomized controlled trial. Obstet Gynecol 2017; 130 (06) 1366-1376